• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

作者信息

DeConti R C, Toftness B R, Lange R C, Creasey W A

出版信息

Cancer Res. 1973 Jun;33(6):1310-5.

PMID:4515709
Abstract
摘要

相似文献

1
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).顺二氨二氯铂（II）的临床与药理学研究。
Cancer Res. 1973 Jun;33(6):1310-5.
2
Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.
Cancer Res. 1972 Jul;32(7):1455-62.
3
Antileukaemic and nephrotoxic properties of platinum compounds.
Nature. 1971 Nov 5;234(5323):43-5. doi: 10.1038/234043a0.
4
Some preliminary observations during the phase I clinical testing of cis-dichlorodiammineplatinum. II.
Neoplasma. 1973;20(2):221-2.
5
Synthesis and distribution of a radiolabeled antitumor agent: cis-diamminedichloroplatinum. II.
J Nucl Med. 1972 May;13(5):328-30.
6
The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.
J Nucl Med. 1973 Apr;14(4):191-5.
7
The effect of cis-platinum (II) diamminodichloride on bone marrow.顺铂（二氯二氨铂）对骨髓的影响。
Cancer Res. 1972 Mar;32(3):595-9.
8
New cancer chemotherapeutic agents.新型癌症化疗药物。
Cancer. 1972 Dec;30(6):1639-46. doi: 10.1002/1097-0142(197212)30:6<1639::aid-cncr2820300633>3.0.co;2-4.
9
DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
Natl Cancer Inst Monogr. 1971 Dec;34:153-9.
10
Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro.抗肿瘤铂化合物对体外培养的哺乳动物细胞中DNA、RNA和蛋白质合成的抑制作用。
Int J Cancer. 1970 Sep 15;6(2):207-16. doi: 10.1002/ijc.2910060207.

引用本文的文献

1
Clinical Use of Cisplatin Liposomes for Patients With Refractory Advanced Cancer.顺铂脂质体在难治性晚期癌症患者中的临床应用
Cureus. 2024 Nov 6;16(11):e73181. doi: 10.7759/cureus.73181. eCollection 2024 Nov.
2
STEP: profiling cellular-specific targets and pathways of bioactive small molecules in tissues integrating single-cell transcriptomics and chemoproteomics.步骤：整合单细胞转录组学和化学蛋白质组学，分析生物活性小分子在组织中的细胞特异性靶点和信号通路。
Chem Sci. 2024 Mar 5;15(12):4313-4321. doi: 10.1039/d3sc04826h. eCollection 2024 Mar 20.
3
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives.
重新审视临床批准的铂类衍生物的抗癌毒性。
Int J Mol Sci. 2022 Dec 6;23(23):15410. doi: 10.3390/ijms232315410.
4
Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011-2022 review.聚合物和金属纳米粒子对顺铂诱导肾毒性的改善作用：2011-2022 年的综述。
J Nanobiotechnology. 2022 Dec 1;20(1):504. doi: 10.1186/s12951-022-01718-w.
5
Colloidal hydroxyethyl starch for tumor-targeted platinum delivery.用于肿瘤靶向铂递送的胶体羟乙基淀粉。
Nanoscale Adv. 2018 Nov 26;1(3):1002-1012. doi: 10.1039/c8na00271a. eCollection 2019 Mar 12.
6
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma.转移性尿路上皮癌患者因肾功能不全而减少顺铂剂量后的肿瘤学结局。
BJUI Compass. 2021 Mar 9;2(5):322-330. doi: 10.1002/bco2.81. eCollection 2021 Sep.
7
Mathematical model of STAT signalling pathways in cancer development and optimal control approaches.癌症发展中STAT信号通路的数学模型及最优控制方法
R Soc Open Sci. 2021 Sep 29;8(9):210594. doi: 10.1098/rsos.210594. eCollection 2021 Sep.
8
Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.吉西他滨联合顺铂辅助化疗在一名接受血液透析的双侧输尿管癌患者中的安全性。
Int Cancer Conf J. 2021 Apr 22;10(3):212-216. doi: 10.1007/s13691-021-00483-1. eCollection 2021 Jul.
9
Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study.在顺铂和依托泊苷治疗小细胞癌患者中给予低剂量聚乙二醇化重组人粒细胞集落刺激因子的安全性和有效性：一项回顾性研究。
Thorac Cancer. 2021 Apr;12(8):1154-1161. doi: 10.1111/1759-7714.13883. Epub 2021 Feb 15.
10
The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry.质谱法揭示铂类抗癌药物在血液中的蛋白质结合行为
Pharmaceuticals (Basel). 2021 Jan 29;14(2):104. doi: 10.3390/ph14020104.